Department of Medicine, Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany.
Department of Medicine, Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Rostock, Germany; Internal Medicine Private Practice, Rostock, Germany.
Ann Palliat Med. 2021 Apr;10(4):3836-3846. doi: 10.21037/apm-20-1346. Epub 2021 Mar 22.
Anxiety and depressive symptoms are commonly reported to have a high prevalence in advanced cancer patients. However, whether the severity of the symptoms change during a stay in a palliative care unit (PCU) and after discharge home has not been studied thus far. This prospective, longitudinal, single-center study screened for anxiety and depression as measured on the German version of Hospital Anxiety and Depression Scale (HADS-D) in a palliative care (PC) cancer cohort at three different time points.
Consecutive patients (N=206) admitted to a PCU were evaluated of whom N=102 could be enrolled. Patients were screened for anxiety and depression using the HADS-D questionnaire: 24 h after admittance (P1), within 24 h before discharge (P2) and 2 weeks after discharge (P3). Longitudinal changes and influencing factors were determined.
Nearly 80% of all patients had at least at one time point a HADS score ≥8 indicating a clinically meaningful symptom burden. The P1 mean scores were 7.1±3.3 (anxiety) and 8.9±4.6 (depression). Depression was associated with underlying cancer type (P<0.05). Anxiety and depression stabilized during hospitalization (P2). However, a significant deterioration after discharge (P3) was observed (anxiety P=0.046; depression P=0.003), in particular in older patients (>65 years) and higher ECOG status (≥3). Patients with a short time since first diagnosis (<1 year) had significantly higher symptom burden compared to patients with a longer disease course. Participation was 50% emphasizing the difficulty to study PC patients. Most patients had advanced cancers (99%). Underlying cancer types consisted of a broad variety of solid tumors including 15% hematological cases. Median survival was 1.1 months.
The high prevalence of anxiety and depressive symptoms points to the need for psychological support. All PC patients should be screened for psychological distress to identify those in need of further assessment and treatment. The deterioration at home suggests the need for improved outpatient management, including home-based psychological support. Caregivers should be aware of the psychological vulnerability of newly diagnosed cancer patients, patients with lower functional status and higher age.
焦虑和抑郁症状在晚期癌症患者中普遍报告有较高的发生率。然而,症状的严重程度在姑息治疗病房(PCU)住院期间和出院回家后是否发生变化,目前尚未研究。这项前瞻性、纵向、单中心研究在三个不同时间点使用德国版医院焦虑和抑郁量表(HADS-D)筛查了姑息治疗(PC)癌症队列中的焦虑和抑郁。
对入住 PCU 的连续患者(N=206)进行评估,其中 N=102 例可入组。患者使用 HADS-D 问卷筛查焦虑和抑郁:入院后 24 小时(P1)、出院前 24 小时内(P2)和出院后 2 周(P3)。确定纵向变化和影响因素。
几乎 80%的患者在至少一个时间点的 HADS 评分≥8,表明存在有临床意义的症状负担。P1 的平均得分分别为 7.1±3.3(焦虑)和 8.9±4.6(抑郁)。抑郁与基础癌症类型相关(P<0.05)。焦虑和抑郁在住院期间稳定(P2)。然而,出院后(P3)观察到显著恶化(焦虑 P=0.046;抑郁 P=0.003),尤其是在年龄较大的患者(>65 岁)和更高的 ECOG 状态(≥3)。首次诊断后时间较短(<1 年)的患者与疾病病程较长的患者相比,症状负担显著更高。参与率为 50%,这强调了研究姑息治疗患者的困难。大多数患者患有晚期癌症(99%)。基础癌症类型包括广泛的实体肿瘤,包括 15%的血液系统病例。中位生存时间为 1.1 个月。
焦虑和抑郁症状的高发生率表明需要心理支持。所有姑息治疗患者都应筛查心理困扰,以确定需要进一步评估和治疗的患者。在家中的恶化表明需要改善门诊管理,包括基于家庭的心理支持。护理人员应意识到新诊断癌症患者、功能状态较低和年龄较大的患者的心理脆弱性。